ArticleACS ES&T engineering2025
How Do Novel PFAS Sorbents Fit into Current Engineering Paradigm?
Article in ACS ES&T engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence-Guided Discovery of Covalent Organic Frameworks for Next-Generation Polyfluoroalkyl Substances Removal.ACS applied materials & interfaces · 2026Review
- Harnessing Fluorine Chemistry: Strategies for Per- and Polyfluoroalkyl Substances Removal and Enrichment.ChemPlusChem · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
As the emergence of novel sorbents brings new possibilities for treatment of per- and polyfluoroalkyl substances (PFAS), drinking water and wastewater utilities face critical decisions in selecting effective, future-ready technologies. With regulatory pressures to address PFAS contamination mounting, however, many utilities may not be in a position to fully evaluate the potential of these novel sorbents and are instead preparing to adopt established technologies that are currently available, such as granular activated carbon (GAC) and ion exchange (IX) resins. Given the expected long life spans of any chosen system, it is important to consider all options, including future treatment innovations. This perspective provides insights into their potential advantages and challenges by exploring the current state of novel sorbents within the broader context of existing technologies. Novel sorbents bring promising benefits, including enhanced selectivity, rapid kinetics, and flexibility for different PFAS chemistries, particularly in challenging matrices such as wastewater. Despite their advantages, significant work remains to refine these materials for large-scale application, including addressing scalability, cost-effectiveness, fouling resistance, and regulatory certification hurdles. By examining key factors for both utilities and novel sorbent developers, this perspective aims to guide informed decisions that balance immediate regulatory compliance with long-term adaptability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.